Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Malignant tumors confirmed by histopathology or cytology, no chemotherapy contraindications, good compliance; (2) Expected survival >6 months; (3) The functional status score is 1 to 2 points, and the Karsten score is = 70 points; (4) There are no gastrointestinal symptoms such as nausea, vomiting, constipation and diarrhea before chemotherapy; (5) organic lesions of important organs such as heart, brain and kidney; (6) According to the condition, at least 2 cycles of the same regimen of chemotherapy should be performed continuously; (7) Patients and their families agree and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) There are gastrointestinal reactions such as nausea and vomiting caused by non-chemotherapeutic factors before chemotherapy; (2) patients with abnormalities in hematuria, liver and kidney function before chemotherapy; (3) If the patient needs to stop or reduce chemotherapy due to non-digestive tract problems after the end of the first cycle; (4) The patient's clinical data is incomplete, affecting the final efficacy judgment; (5) malignant tumors, brain metastases, intracranial hypertension, vomiting caused by digestive tract obstruction (6) Patients and their families have not signed; (7) Patients participate in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effect; | — |
Contacts
TCM-Intergrated of Southern Medical University